Tenet Healthcare (THC) Gains from Investment Securities (2009 - 2026)

Tenet Healthcare (THC) has 18 years of Gains from Investment Securities data on file, last reported at $8.0 million in Q1 2026.

• Quarterly Gains from Investment Securities rose 260.0% year-over-year to $8.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 11.76% YoY) and the FY2025 annual result came in at $6.0 million, down 68.42% from the prior year.
• Gains from Investment Securities improved to $8.0 million in Q1 2026 per THC's latest filing, from -$323.0 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $328.0 million in Q3 2025, with the low at -$323.0 million in Q4 2025.
• Average Gains from Investment Securities over 5 years is $1.6 million, with a median of $6.0 million recorded in 2024.
• The widest YoY moves for Gains from Investment Securities: up 5366.67% in 2025, down 3330.0% in 2025.
• Tenet Healthcare's Gains from Investment Securities stood at -$19.0 million in 2022, then sank by 994.74% to -$208.0 million in 2023, then jumped by 104.81% to $10.0 million in 2024, then plunged by 3330.0% to -$323.0 million in 2025, then surged by 102.48% to $8.0 million in 2026.
• Business Quant data shows THC's Gains from Investment Securities at $8.0 million in Q1 2026, -$323.0 million in Q4 2025, and $328.0 million in Q3 2025.